Skip to main content
AAPL-0.36%MSFT+0.84%NVDA+3.92%GOOGL-1.24%AMZN+0.73%TSM-3.68%SPCX+3.16%AVGO+2.46%META+0.61%TSLA+0.92%LLY-1.13%BRK-B-1.03%WMT-0.69%JPM-2.44%SKHY+0.35%AMD-0.17%MU+4.23%V-2.27%XOM+0.20%JNJ-1.36%MA-2.41%ASMLa-5.34%ABBV-0.59%COST-0.33%1398.HK-0.99%0700.HK-3.69%KO-0.69%CVX-0.47%PG-0.75%CSCO+0.62%0939.HK-0.84%UNH-5.42%ORCL-3.38%3988.HK-0.63%BAC-1.28%HD-2.45%GE+0.38%0857.HK-0.38%1816.HK-2.30%1288.HK-0.86%0005.HK-1.42%PM-0.85%NVS-0.67%HSBA.L-1.95%MS-1.10%INTC-0.54%AZN-0.95%AMAT-0.29%AP2d-4.07%TXN+0.56%AUDJPY-0.63%NZDJPY-0.62%AUDUSD-0.53%NZDUSD-0.49%GBPAUD+0.44%EURJPY-0.43%GBPNZD+0.43%GBPTRY+0.41%CHFJPY-0.40%CADJPY-0.35%GBPHKD+0.32%USDCHF+0.32%EURUSD-0.31%AUDCAD-0.29%GBPMXN-0.28%NZDCAD-0.27%GBPCHF+0.25%AUDCHF-0.24%EURGBP-0.24%USDCAD+0.24%EURAUD+0.22%NZDCHF-0.20%GBPJPY-0.18%EURNZD+0.18%USDTHB-0.18%GBPCAD+0.16%USDILS+0.16%USDTRY+0.16%USDJPY-0.13%USDCNH-0.11%USDDKK+0.10%NZDMXN+0.09%AUDNOK+0.09%EURCNH-0.09%CHFSGD-0.09%NZDSGD+0.08%EURSGD-0.08%CADCHF+0.07%EURCAD-0.07%SGDJPY+0.07%GBPUSD-0.06%AUDSGD+0.04%USDCOP-0.04%AUDNZD-0.04%USDMXN+0.03%GBPSGD-0.02%USDSGD+0.02%EURCHF+0.01%USDHKD+0.01%USDZAR-0.01%EURDKK0.00%CHFNOK0.00%EURNOK0.00%EURSEK0.00%EURCZK0.00%NOKJPY0.00%USDPLN0.00%GBPZAR0.00%PLNJPY0.00%USDNOK0.00%USDSEK0.00%EURHKD0.00%EURPLN0.00%EURZAR0.00%AUDDKK0.00%CHFSEK0.00%XNGUSD+0.66%GAUUSD-0.25%XAUUSD-0.25%GAGUSD-0.19%XAGUSD-0.19%XPTUSD-0.16%USOIL-0.06%HG1+0.04%COFFEE0.00%COCOA0.00%W10.00%S10.00%BTCUSD-0.06%ETHUSD+58.05%USDTUSD-0.01%XRPUSD+57.05%SOLUSD+65.46%TRXUSDT+0.99%ZECUSDT+6.64%XMRUSDT+3.18%DOGEUSD+59.04%LINKUSD+1.49%XLMUSD+2.73%BCHUSDT+1.59%LTCUSD+50.36%UNIUSD+2.32%TONUSD+63.46%SUIUSD+2.22%HBARUSDT+1.20%TAOUSDT+3.06%AAVEUSD+3.40%ONDOUSDT+1.11%ICPUSDT-8.38%DOTUSDT+1.32%WLDUSDT+2.24%ARBUSDT+0.83%INJUSDT+7.93%ATOMUSDT-0.32%STXUSDT+5.89%PYTHUSDT+2.26%TIAUSDT+0.91%FETUSDT+0.68%SEIUSDT+3.60%JUPUSDT+8.60%GRTUSDT+4.68%OPUSDT-2.36%IOTAUSDT+3.18%POLUSDT+4.29%WIFUSDT+1.17%AXSUSDT+1.71%EOSUSDT+2.67%FARTCOINUSDT-1.03%IMXUSDT+3.03%GALAUSDT-1.23%DYDXUSDT+2.54%ORDIUSDT+0.39%NOTUSDT+1.77%RONINUSDT+2.00%AAPL-0.36%MSFT+0.84%NVDA+3.92%GOOGL-1.24%AMZN+0.73%TSM-3.68%SPCX+3.16%AVGO+2.46%META+0.61%TSLA+0.92%LLY-1.13%BRK-B-1.03%WMT-0.69%JPM-2.44%SKHY+0.35%AMD-0.17%MU+4.23%V-2.27%XOM+0.20%JNJ-1.36%MA-2.41%ASMLa-5.34%ABBV-0.59%COST-0.33%1398.HK-0.99%0700.HK-3.69%KO-0.69%CVX-0.47%PG-0.75%CSCO+0.62%0939.HK-0.84%UNH-5.42%ORCL-3.38%3988.HK-0.63%BAC-1.28%HD-2.45%GE+0.38%0857.HK-0.38%1816.HK-2.30%1288.HK-0.86%0005.HK-1.42%PM-0.85%NVS-0.67%HSBA.L-1.95%MS-1.10%INTC-0.54%AZN-0.95%AMAT-0.29%AP2d-4.07%TXN+0.56%AUDJPY-0.63%NZDJPY-0.62%AUDUSD-0.53%NZDUSD-0.49%GBPAUD+0.44%EURJPY-0.43%GBPNZD+0.43%GBPTRY+0.41%CHFJPY-0.40%CADJPY-0.35%GBPHKD+0.32%USDCHF+0.32%EURUSD-0.31%AUDCAD-0.29%GBPMXN-0.28%NZDCAD-0.27%GBPCHF+0.25%AUDCHF-0.24%EURGBP-0.24%USDCAD+0.24%EURAUD+0.22%NZDCHF-0.20%GBPJPY-0.18%EURNZD+0.18%USDTHB-0.18%GBPCAD+0.16%USDILS+0.16%USDTRY+0.16%USDJPY-0.13%USDCNH-0.11%USDDKK+0.10%NZDMXN+0.09%AUDNOK+0.09%EURCNH-0.09%CHFSGD-0.09%NZDSGD+0.08%EURSGD-0.08%CADCHF+0.07%EURCAD-0.07%SGDJPY+0.07%GBPUSD-0.06%AUDSGD+0.04%USDCOP-0.04%AUDNZD-0.04%USDMXN+0.03%GBPSGD-0.02%USDSGD+0.02%EURCHF+0.01%USDHKD+0.01%USDZAR-0.01%EURDKK0.00%CHFNOK0.00%EURNOK0.00%EURSEK0.00%EURCZK0.00%NOKJPY0.00%USDPLN0.00%GBPZAR0.00%PLNJPY0.00%USDNOK0.00%USDSEK0.00%EURHKD0.00%EURPLN0.00%EURZAR0.00%AUDDKK0.00%CHFSEK0.00%XNGUSD+0.66%GAUUSD-0.25%XAUUSD-0.25%GAGUSD-0.19%XAGUSD-0.19%XPTUSD-0.16%USOIL-0.06%HG1+0.04%COFFEE0.00%COCOA0.00%W10.00%S10.00%BTCUSD-0.06%ETHUSD+58.05%USDTUSD-0.01%XRPUSD+57.05%SOLUSD+65.46%TRXUSDT+0.99%ZECUSDT+6.64%XMRUSDT+3.18%DOGEUSD+59.04%LINKUSD+1.49%XLMUSD+2.73%BCHUSDT+1.59%LTCUSD+50.36%UNIUSD+2.32%TONUSD+63.46%SUIUSD+2.22%HBARUSDT+1.20%TAOUSDT+3.06%AAVEUSD+3.40%ONDOUSDT+1.11%ICPUSDT-8.38%DOTUSDT+1.32%WLDUSDT+2.24%ARBUSDT+0.83%INJUSDT+7.93%ATOMUSDT-0.32%STXUSDT+5.89%PYTHUSDT+2.26%TIAUSDT+0.91%FETUSDT+0.68%SEIUSDT+3.60%JUPUSDT+8.60%GRTUSDT+4.68%OPUSDT-2.36%IOTAUSDT+3.18%POLUSDT+4.29%WIFUSDT+1.17%AXSUSDT+1.71%EOSUSDT+2.67%FARTCOINUSDT-1.03%IMXUSDT+3.03%GALAUSDT-1.23%DYDXUSDT+2.54%ORDIUSDT+0.39%NOTUSDT+1.77%RONINUSDT+2.00%
AB

AbbVie Inc. (ABBV)

NYSE • Healthcare

$292.82
-$1.73 (-0.6%)
Market closed

November 17, 2026 at 21:00 UTC

Open$291.5
Day Range$291 - $294.06
Avg. Volume (3M)5.1M
Market Cap$517.1B
P/E Ratio50.2
52 Week Range
$190.75$302.93
Next EarningsIn 77 daysFeb 3, 2027

Interactive Chart

00:18:58 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$17.4B100%
Gross Profitminus cost of goods$13.1B75%
Operating Incomeminus R&D and overhead$6.2B36%
Net Incomeminus taxes and the rest$4.2B24%

In plain terms: out of every $100 in revenue, AbbVie Inc. keeps $24 as net profit.

Fundamentals & Financials

Revenue (TTM)
$66B
Net Income (TTM)
$10.3B
EPS (TTM)
$5.83
ROA (TTM)
7%
Current Ratio
0.87
Dividend Yield
0.66%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+2.3%Q2 2026$2.65
+1.1%Q3 2026$3.65
+2.4%Q4 2026$3.82
Next

Feb 3

in 77 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +2.4%

AbbVie’s adjusted EPS topped expectations while revenue came in line in the third fiscal quarter of 2026, based on preliminary results reported October 30, 2026. Adjusted EPS was $3.82 versus a $3.73 estimate (+2.4%, topped), as revenue rose 10.3% to roughly $17.4 billion (up from about $15.8 billion a year ago) and revenue of $17.404 billion was in line with a $17.316 billion estimate (+0.5%). Profitability remained high, with gross margin at about 85% and operating margin near 37%, as gross profit came in around $14.8 billion and operating income was roughly $6.5 billion. Net income was about $4.2 billion, up 2169.9% from roughly $186.0 million a year ago. Consensus for the next period calls for EPS of $3.90 on revenue of $18.284 billion.

View full earnings history

About AbbVie Inc.

AbbVie Inc. (NYSE: ABBV) is a healthcare company that discovers, develops, manufactures, and commercializes advanced medicines across immunology, oncology, neuroscience, eye care, and other therapeutic areas around the world. In Drug Manufacturers - General, AbbVie generated $61.2 billion of revenue in FY2025.

Name
AbbVie Inc.
CEO
Robert A. Michael
Industry
Healthcare
Year Founded
2012
Employees
57,000

Today's Snapshot

AI-generated

The day ended with ABBV 0.6% lower at 292.78, in line with a weaker sector. Trading was lighter than usual, with volume about half of its usual level.

Trading Volume

Below 10d avg (5.0M)

2.4M

vs S&P 500 Today

Outperforming Market

+0.75%

Updated: November 17, 2026 at 21:12 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
ABBV is trading around 292.82 with a broadly constructive technical profile driven by a discernible trend and steady momentum. ADX near 30 points to a reasonably strong trend, while momentum measures are mixed—RSI and MACD sit in neutral territory even as short-term momentum shows modest positive bias—leaving internals balanced. Price is hovering near the very short-term averages but remains well above the 200‑day trend, which supports the longer-term backdrop. Volatility is moderate with ATR around 2.3%, and on‑balance volume is not clearly supportive. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$248.49 - $292.85
    Buy
  • RSI (14)58.70
    Neutral
  • Stochastic %K (14, 3, 3)59.76
    Neutral
  • MACD Level (12, 26)4.79
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.